Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Genetronics Biomedical (AMEX:GEB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
11199 Sorrento Valley Road
San Diego, CA 92121
Phone: (858) 597-6006
Fax: (858) 597-0119
Email: ir@genetronics.com.
Employees (last reported count): 66
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 37%
·Institutional: 14% (22% of float)
(10 institutions)
·Net Inst. Buying: 271.0K shares (+5.39%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Genetronics Biomedical Corporation, formerly known as Genetronics Biomedical Ltd., is a drug and gene delivery company specializing in developing technology and hardware focused on electroporation. Electroporation is the application of brief, controlled pulsed electric fields to cells, which cause tiny pores to temporarily open in the cell membrane. The Company conducts business through its operating subsidiary Genetronics, Inc. The Company operates through two divisions: the Drug and Gene Delivery Division, through which the Company is developing drug and gene delivery systems based on electroporation to be used in the treatment of disease; and the BTX Instrument Division, which develops, manufactures, and sells electroporation equipment to the research laboratory market for in vitro and for in vivo animal experimentation.
More from Market Guide: Expanded Business Description

Financial Summary
GEB develops, manufactures, and markets electroporation instrumentation and accessories used to perform genetic engineering techniques, such as cell fusion, gene transfer, cell membrane research and genetic mapping. For the three months ended 6/30/01, revenues fell 38% to $899 thousand. Net loss before accouting change rose 38% to $2.7 million. Revenues reflect lower sales due to the economic decline. Net loss also reflects an increase in salary related expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
James Heppell, 44Interim Chairman
Grant Denison, Jr., 50Pres, CEO, Director
Mervyn McCulloch, 57CFO
Terry GibsonCOO
Babak Nemati, Ph.D.VP, Corp. Devel.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:GEBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$0.50 
Recent Price$0.70 
52-Week High
on 6-Sep-2000
$2.50 
Beta2.78 
Daily Volume (3-month avg)21.3K
Daily Volume (10-day avg)10.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-71.3%
52-Week Change
relative to S&P500
-61.5%
Share-Related Items
Market Capitalization$23.6M
Shares Outstanding33.8M
Float21.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.22 
Earnings (ttm)-$0.31 
Earnings (mrq)-$0.08 
Sales (ttm)$0.17 
Cash (mrq)$0.12 
Valuation Ratios
Price/Book (mrq)3.23 
Price/EarningsN/A 
Price/Sales (ttm)4.23 
Income Statements
Sales (ttm)$4.99M
EBITDA (ttm)-$8.66M
Income available to common (ttm)-$9.37M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-87.92%
Return on Equity (ttm)-104.55%
Financial Strength
Current Ratio (mrq)3.83 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$4.00M
Short Interest
As of 8-Aug-2001
Shares Short11.0K
Percent of Float0.1%
Shares Short
(Prior Month)
11.0K
Short Ratio0.79 
Daily Volume14.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.